STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 100 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 2.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $10,000 | -94.1% | 2,172 | -86.7% | 0.00% | – |
| Q3 2019 | $170,000 | +226.9% | 16,334 | +375.1% | 0.00% | – |
| Q2 2019 | $52,000 | -60.0% | 3,438 | -66.2% | 0.00% | – |
| Q1 2019 | $130,000 | -62.2% | 10,167 | -72.0% | 0.00% | -100.0% |
| Q4 2018 | $344,000 | +124.8% | 36,307 | +291.7% | 0.00% | – |
| Q3 2018 | $153,000 | +36.6% | 9,270 | +31.7% | 0.00% | – |
| Q2 2018 | $112,000 | -33.3% | 7,038 | -36.0% | 0.00% | -100.0% |
| Q1 2018 | $168,000 | +25.4% | 10,994 | +27.9% | 0.01% | +16.7% |
| Q4 2017 | $134,000 | +28.8% | 8,594 | -8.9% | 0.01% | +50.0% |
| Q3 2017 | $104,000 | +225.0% | 9,436 | +165.2% | 0.00% | +300.0% |
| Q2 2017 | $32,000 | -47.5% | 3,558 | -50.3% | 0.00% | -66.7% |
| Q1 2017 | $61,000 | +771.4% | 7,155 | +966.3% | 0.00% | – |
| Q3 2016 | $7,000 | -84.8% | 671 | -93.2% | 0.00% | -100.0% |
| Q1 2016 | $46,000 | – | 9,883 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 475,200 | $6,877,000 | 3.03% |
| Avoro Capital Advisors LLC | 475,000 | $6,873,000 | 2.64% |
| VHCP Management, LLC | 451,400 | $6,532,000 | 1.50% |
| Sio Capital Management, LLC | 140,000 | $2,026,000 | 1.15% |
| Opus Point Partners Management, LLC | 75,000 | $1,085,000 | 0.91% |
| Eventide Asset Management | 620,200 | $8,974,000 | 0.68% |
| Telemetry Investments, L.L.C. | 55,000 | $796,000 | 0.44% |
| Healthcare Value Capital, LLC | 25,000 | $362,000 | 0.40% |
| TFS CAPITAL LLC | 259,916 | $3,761,000 | 0.37% |
| FARALLON CAPITAL MANAGEMENT LLC | 672,562 | $9,732,000 | 0.14% |